“…RNAa can be triggered by both artificially designed small activating RNAs (saRNAs) and endogenous small RNAs that target gene regulatory sequences or coding regions [2][3][4][5][6][7][8]. RNAa appears to be conserved in evolution, being present in animals ranging from Caenorhabditis elegans (C. elegans) to human [1,2,5]. Despite that the detailed mechanism for RNAa awaits to be elucidated, this unparalleled approach of sequence-specific activation of endogenous gene expression can obviously be harnessed for a number of purposes such as disease treatment [9,10] and cell fate reprogramming.…”